<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="4.3.4">Jekyll</generator><link href="https://researchwaste.info/feed.xml" rel="self" type="application/atom+xml" /><link href="https://researchwaste.info/" rel="alternate" type="text/html" /><updated>2026-06-12T07:57:45+00:00</updated><id>https://researchwaste.info/feed.xml</id><title type="html">ResearchWaste.info</title><subtitle>AWARE is a research project in progress at the University of Toronto and the SPOR Evidence Alliance focused on reducing research waste in health and biomedical sciences.</subtitle><author><name>Pavel Zhelnov</name></author><entry><title type="html">Dr. Lisa Ridgway, JD. Remembrance note</title><link href="https://researchwaste.info/2026/01/29/lisa-ridgway" rel="alternate" type="text/html" title="Dr. Lisa Ridgway, JD. Remembrance note" /><published>2026-01-29T00:00:00+00:00</published><updated>2026-01-29T00:00:00+00:00</updated><id>https://researchwaste.info/2026/01/29/lisa-ridgway</id><content type="html" xml:base="https://researchwaste.info/2026/01/29/lisa-ridgway"><![CDATA[<div class="mem-wrap">
  <img class="mem-img" alt="Lisa Ridgway Portrait" src="/assets/media/Lisa_Ridgway.png" />
  <p>Lisa Ridgway passed away on November 14<sup>th</sup>, 2025. I learned of her death through a bounce-back email, ending abruptly just over a year of our research partnership.</p>
  <p>Lisa Ridgway’s passing is an irreparable loss that I mourn. What remains in my heart is her unbeatable energy and her determination for patient leadership in research.</p>
  <div style="clear:both;"></div>
</div>

<p>Lisa had been involved in patient-oriented research since 2018. She was a lawyer by training and profession, a Research Ambassador for <a href="https://cihr-irsc.gc.ca/e/41204.html">Canada’s Strategy for Patient-Oriented Research</a> (SPOR) <a href="https://healthresearchbc.ca/bc-support-unit/about-us/">BC Support Unit</a>, and a peer-reviewed author.</p>

<p>Here is a snippet from Lisa’s profile on <a href="https://web.archive.org/web/20260129182423/https://www.researchgate.net/profile/Lisa-Ridgway">ResearchGate</a>:</p>

<blockquote>
  <p>My research work is at the cross-section of patient engagement / experience, medicine (eg. biomarkers, pharmacogenomics, major depressive disorder) and non-interventional and interventional therapy (eg. rTMS), all in mental health. I am a regional, provincial and national research ambassador in Canada for patient-oriented research. My focus is on the one absolute, that is, that mental health is health. I also live, work and play on the un-ceded land of the Lek’wungen peoples and nation.</p>
</blockquote>

<p>I encourage you to read Lisa’s – in her own words – “ode to partnership and many years collaborating with the BC SUPPORT Unit.” I recall that she was glad to see it finally published, after some back-and-forth with the journals, in the summer of 2025.</p>

<blockquote>
  <p>Ridgway, L., &amp; Loo, S. (2025). Patient-oriented research- it’s personal: two BC SUPPORT unit patient partners sharing their journey in patient-oriented research. <em>Research involvement and engagement</em>, 11(1), 89. <a href="https://doi.org/10.1186/s40900-025-00764-6">https://doi.org/10.1186/s40900-025-00764-6</a></p>
</blockquote>

<p>Lisa’s contributions to <a href="https://docs.google.com/document/d/1kHBxe7XmJcfp8T32QxAjJqqPs_LRu4EIM4cpa_GWT7E/edit">AWARE</a> are invaluable.</p>

<p>She was the one who proposed to offer focus groups, in addition to interviews, suggesting that some patient partners might feel more comfortable sharing as part of a group.</p>

<p>She shared valuable insights into the potential power dynamics of our planned Steering Committee.</p>

<p>We would brainstorm over Zoom, in emails, and in the comments on <a href="https://www.linkedin.com/in/lisa-ridgway-5371582b7/">LinkedIn</a>, conceptualizing research waste through a patient partner’s eyes. It was through these discussions that I learned that <a href="https://blogs.bmj.com/bmj/2016/01/14/paul-glasziou-and-iain-chalmers-is-85-of-health-research-really-wasted/">research waste</a> and <a href="https://archive.ph/PtxIt">misconduct</a> are conceptually fuzzy from a general public point of view.</p>

<p>It was Lisa who clarified that the use cases for a research waste tool, for a patient partner, could fall into different categories: 1) when invited to join a research team (before, during, after); 2) as a peer reviewer; 3) when “shopping around” – at informal journal clubs where patient partners will get together and talk about papers.</p>

<p><a href="https://www.womeninneed.ca/">The SPOR Evidence Alliance</a> has shared messages of condolence with Lisa’s husband on behalf of the team and has made a donation to <a href="https://www.womeninneed.ca/">Victoria Women in Need Community Cooperative</a> charity, of which Lisa was a strong supporter, in her memory.</p>

<p>“Go, go, go!” – as Lisa would say to me!</p>]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[Lisa Ridgway passed away on November 14th, 2025. I learned of her death through a bounce-back email, ending abruptly just over a year of our research partnership. Lisa Ridgway’s passing is an irreparable loss that I mourn. What remains in my heart is her unbeatable energy and her determination for patient leadership in research.]]></summary></entry><entry><title type="html">Supplementary data for KTP Town Hall</title><link href="https://researchwaste.info/2025/08/26/ktp-town-hall" rel="alternate" type="text/html" title="Supplementary data for KTP Town Hall" /><published>2025-08-26T00:00:00+00:00</published><updated>2025-08-26T00:00:00+00:00</updated><id>https://researchwaste.info/2025/08/26/ktp-town-hall</id><content type="html" xml:base="https://researchwaste.info/2025/08/26/ktp-town-hall"><![CDATA[<p><img src="/assets/media/ktp_logo.png" alt="Knowledge Translation Program Logo" /></p>

<p>I am pleased to let everyone know that I am presenting the research work accomplished to date at a <a href="https://knowledgetranslation.net/">Knowledge Translation Program</a> town hall. This is a local event held at St. Michael’s Hospital (Unity Health Toronto), which I am affiliated with.</p>

<h2 id="event-details">Event details</h2>

<p><strong>Topic: ResearchWaste.info: Raising awareness of avoidable waste in health research</strong></p>

<p>My oral presentation is scheduled for Tuesday August 26th at 10:35-10:40am EDT (UTC-4) as a Knowledge Synthesis Graduate Student Featured Project. Location: Toronto, Ontario, Canada.</p>

<p>📍 <a href="https://maps.app.goo.gl/Y9naD13LHbHSsk6M6">Li Ka Shing Knowledge Institute</a>, Meeting Room 136, 1st Floor, 209 Victoria St</p>

<h2 id="slide-deck">Slide deck</h2>

<p>This is a local event with the Knowledge Translation Program and, as such, may not be available to the public. However, feel free to download my slide deck (licensed under <a href="https://creativecommons.org/licenses/by-sa/4.0/">CC BY-SA 4.0 International</a>):</p>

<p><a href="/assets/pptx/KTP_Zhelnov_2025-08-26.pptx">Slide Deck - PowerPoint</a></p>

<p><a href="/assets/pdf/KTP_Zhelnov_2025-08-26.pdf">Slide Deck - PDF</a></p>

<h2 id="other-supplementary-data">Other supplementary data</h2>

<p>There are a number of other locations where findings were shared (as of August 26, 2025):</p>

<ul>
  <li>
    <p><strong>Resource:</strong> News on ResearchWaste.info</p>

    <p><strong>Last Updated:</strong> August 26, 2025</p>

    <p><strong>Link:</strong> <a href="https://researchwaste.info">https://researchwaste.info</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> LinkedIn Social Media Page</p>

    <p><strong>Last Updated:</strong> August 22, 2025</p>

    <p><strong>Link:</strong> <a href="https://www.linkedin.com/in/drzhelnov">https://www.linkedin.com/in/drzhelnov</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> Poster presented at the Unity Health Toronto RTC Research Day 2025</p>

    <p><strong>Last Updated:</strong> May 26, 2025</p>

    <p><strong>Link:</strong> <a href="https://researchwaste.info/2025/05/26/rtc-research-day">https://researchwaste.info/2025/05/26/rtc-research-day</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> Materials shared at the IHPME Research and Impact Day 2025</p>

    <p><strong>Last Updated:</strong> May 5, 2025</p>

    <p><strong>Link:</strong> <a href="https://researchwaste.info/2025/05/05/ihpme-research-and-impact-day">https://researchwaste.info/2025/05/05/ihpme-research-and-impact-day</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> Proposal Community Draft – Request For Comments</p>

    <p><strong>Last Updated:</strong> March 23, 2025</p>

    <p><strong>Link:</strong> <a href="https://docs.google.com/document/d/1kHBxe7XmJcfp8T32QxAjJqqPs_LRu4EIM4cpa_GWT7E/edit">https://docs.google.com/document/d/1kHBxe7XmJcfp8T32QxAjJqqPs_LRu4EIM4cpa_GWT7E/edit</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> Repository on Open Science Framework</p>

    <p><strong>Last Updated:</strong> January 24, 2025</p>

    <p><strong>Link:</strong> <a href="https://doi.org/10.17605/OSF.IO/E87V2">https://doi.org/10.17605/OSF.IO/E87V2</a></p>
  </li>
</ul>

<h2 id="call-for-feedback">Call for feedback</h2>

<p>Have any feedback? Let me know on <a href="https://www.linkedin.com/in/drzhelnov">LinkedIn</a> or via this <a href="/contact/">feedback form</a>.</p>]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[]]></summary></entry><entry><title type="html">Reproducible AI: study within a study</title><link href="https://researchwaste.info/2025/06/20/gemma-swas" rel="alternate" type="text/html" title="Reproducible AI: study within a study" /><published>2025-06-20T00:00:00+00:00</published><updated>2025-06-20T00:00:00+00:00</updated><id>https://researchwaste.info/2025/06/20/gemma-swas</id><content type="html" xml:base="https://researchwaste.info/2025/06/20/gemma-swas"><![CDATA[<!---ollama create gemma-3-27b-it-qat-q4_0-gguf:17cf0f6 -f /Volumes/home/anonymous/models/gemma-3-27b-it-qat/Modelfile--->]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[]]></summary></entry><entry><title type="html">Supplementary data for RTC Research Day 2025</title><link href="https://researchwaste.info/2025/05/26/rtc-research-day" rel="alternate" type="text/html" title="Supplementary data for RTC Research Day 2025" /><published>2025-05-26T00:00:00+00:00</published><updated>2025-05-26T00:00:00+00:00</updated><id>https://researchwaste.info/2025/05/26/rtc-research-day</id><content type="html" xml:base="https://researchwaste.info/2025/05/26/rtc-research-day"><![CDATA[<p><img src="/assets/media/rtc_research_day_2025_logo.png" alt="Logo of RTC Research Day 2025 - Research Training Centre of St. Michael’s Hospital, Unity Health Toronto" /></p>

<p>I am pleased to let everyone know that I am presenting the research work accomplished to date at the <a href="https://research.unityhealth.to/events/rtc-research-day-2025/">RTC Research Day 2025</a>. This is a local event held annually at the Research Training Centre of St. Michael’s Hospital (Unity Health Toronto), which I am affiliated with.</p>

<h2 id="event-details">Event details</h2>

<p><strong>Topic: ResearchWaste.info: Raising awareness of avoidable waste in health research</strong></p>

<p>My presentation is included in the Clinical Research (Dry Bench) Stream poster session scheduled for Tuesday May 27th at 12:40–2:00pm EDT (UTC-4). Location: Toronto, Ontario, Canada.</p>

<p>📍 <a href="https://maps.app.goo.gl/Y9naD13LHbHSsk6M6">Li Ka Shing (LKS) Knowledge Institute</a>, 2nd Floor, B&amp;M Syron Exhibit Hall, LKS 240 &amp; LKS 241; 209 Victoria St</p>

<h2 id="virtual-participation">Virtual participation</h2>

<p>As far as I know, no virtual broadcast nor recording are planned this year. However, feel free to download my print-ready poster (licensed under <a href="https://creativecommons.org/licenses/by-sa/4.0/">CC BY-SA 4.0 International</a>):</p>

<p><a href="/assets/pdf/Pavel_Zhelnov_2025-05-27_1240-1400_RTC_LKSI_48x36in_v12.pdf">48 × 36 inches Poster - PDF</a></p>

<p>Also, the accompanying abstract is published on p. 34 (# 23) of the program book:</p>

<p><a href="/assets/pdf/rtc-rd-2025-program-guide-final.pdf">Full Program Guide - PDF</a></p>

<h2 id="other-supplementary-data">Other supplementary data</h2>

<p>There are a number of other locations where findings were shared (as of May 26, 2025):</p>

<ul>
  <li>
    <p><strong>Resource:</strong> News on ResearchWaste.info</p>

    <p><strong>Last Updated:</strong> May 26, 2025</p>

    <p><strong>Link:</strong> <a href="https://researchwaste.info">https://researchwaste.info</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> LinkedIn Social Media Page</p>

    <p><strong>Last Updated:</strong> May 18, 2025</p>

    <p><strong>Link:</strong> <a href="https://www.linkedin.com/in/drzhelnov">https://www.linkedin.com/in/drzhelnov</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> Materials shared at the IHPME Research and Impact Day 2025</p>

    <p><strong>Last Updated:</strong> May 5, 2025</p>

    <p><strong>Link:</strong> <a href="https://researchwaste.info/2025/05/05/ihpme-research-and-impact-day">https://researchwaste.info/2025/05/05/ihpme-research-and-impact-day</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> Proposal Community Draft – Request For Comments</p>

    <p><strong>Last Updated:</strong> March 23, 2025</p>

    <p><strong>Link:</strong> <a href="https://docs.google.com/document/d/1kHBxe7XmJcfp8T32QxAjJqqPs_LRu4EIM4cpa_GWT7E/edit">https://docs.google.com/document/d/1kHBxe7XmJcfp8T32QxAjJqqPs_LRu4EIM4cpa_GWT7E/edit</a></p>
  </li>
  <li>
    <p><strong>Resource:</strong> Repository on Open Science Framework</p>

    <p><strong>Last Updated:</strong> January 24, 2025</p>

    <p><strong>Link:</strong> <a href="https://doi.org/10.17605/OSF.IO/E87V2">https://doi.org/10.17605/OSF.IO/E87V2</a></p>
  </li>
</ul>

<h2 id="call-for-feedback">Call for feedback</h2>

<p>Have any feedback? Let me know on <a href="https://www.linkedin.com/in/drzhelnov">LinkedIn</a> or via this <a href="/contact/">feedback form</a>.</p>]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[]]></summary></entry><entry><title type="html">Ethical and philosophical critique of research waste—DeepSeek-R1</title><link href="https://researchwaste.info/2025/05/18/moral-authority-research-waste.html" rel="alternate" type="text/html" title="Ethical and philosophical critique of research waste—DeepSeek-R1" /><published>2025-05-18T00:00:00+00:00</published><updated>2025-05-18T00:00:00+00:00</updated><id>https://researchwaste.info/2025/05/18/moral-authority-research-waste</id><content type="html" xml:base="https://researchwaste.info/2025/05/18/moral-authority-research-waste.html"><![CDATA[<p><strong>User:</strong> I am doing a thesis on research waste, but I keep wondering: Is there such a thing as research waste? If the study in question received proper ethical review board approval, the principal investigator qualified for funding, and we assume no outright misconduct (e.g., no fabrication, falsification, plagiarism), do we have the moral authority to claim that the study should not have happened? Perhaps philosophers in the room could help me out.</p>

<p><strong>DeepSeek-R1:</strong></p>

<blockquote>
  <p><strong>Thought for 17 seconds</strong></p>

  <p>Okay, so I need to figure out if research waste is a real thing, even when a study has all the proper approvals and no misconduct. The user mentioned their thesis on research waste and is questioning if we can morally say a study shouldn’t have happened under those conditions. Let me break this down.</p>

  <p>First, what is research waste? From what I know, it’s when resources are used in studies that don’t add value—maybe they’re redundant, poorly designed, not published, or not disseminated properly. But if a study got ethical approval and funding, does that mean it’s not wasteful? Maybe not. Even with approvals, a study might not address a real need, or maybe the methodology is flawed, leading to unreliable results. Or perhaps the question it’s answering isn’t useful anymore.</p>

  <p>Ethical approval usually focuses on participant safety and rights, not necessarily the study’s value or potential for waste. Similarly, funding agencies might prioritize certain areas, but maybe they don’t check if the research is redundant. So even if a study is ethical, it could still be wasteful if it doesn’t contribute meaningfully.</p>

  <p>Then there’s the moral authority part. If a study isn’t unethical per se, but just not useful, do we have the right to say it shouldn’t have been done? Philosophers might argue about the moral responsibilities of researchers. Utilitarianism would look at the greatest good; if the resources could have been used for better research, then maybe it’s wasteful. Deontological ethics might focus on the duty of researchers to maximize benefit and minimize harm, which includes avoiding waste.</p>

  <p>Also, opportunity cost: the resources (money, time, participants) used in a wasteful study could have been used elsewhere. Even without misconduct, if a study doesn’t add to knowledge or improve practice, it’s a missed opportunity.</p>

  <p>Another angle is epistemic responsibility. Researchers have a duty to contribute to collective knowledge. If a study doesn’t do that, it’s failing this responsibility, even if it’s not unethical in a traditional sense.</p>

  <p>There’s also the issue of publication bias and non-dissemination. If results aren’t shared, especially negative ones, that’s a form of waste too. But the user assumes no misconduct, so maybe the study is published, but maybe it’s just not useful.</p>

  <p>So, putting it all together: Yes, research waste exists even with ethical approval and funding. The moral authority comes from the broader responsibilities of researchers to use resources wisely, contribute to knowledge, and consider the opportunity costs. Philosophical frameworks support the idea that waste is a moral issue beyond just ethics approval.</p>
</blockquote>

<p>The concept of research waste is indeed valid, even when studies have ethical approval, qualified funding, and no misconduct. Here’s a structured analysis grounded in ethical and philosophical reasoning:</p>

<h3 id="1-defining-research-waste">1. <strong>Defining Research Waste</strong></h3>
<ul>
  <li><strong>Concept</strong>: Research waste refers to the inefficient use of resources (funding, time, expertise, participant involvement) in studies that fail to generate meaningful knowledge, address pressing needs, or translate into societal benefit. This includes redundant, poorly designed, or non-disseminated research.</li>
  <li><strong>Key Sources</strong>:
    <ul>
      <li><strong>Redundancy</strong>: Replicating studies without novel insights or addressing gaps.</li>
      <li><strong>Poor Prioritization</strong>: Investigating low-impact questions while urgent issues are neglected.</li>
      <li><strong>Methodological Flaws</strong>: Studies with design weaknesses that compromise validity.</li>
      <li><strong>Non-Dissemination</strong>: Unpublished results (even negative ones) that leave knowledge incomplete.</li>
    </ul>
  </li>
</ul>

<h3 id="2-ethical-approval--absence-of-waste">2. <strong>Ethical Approval ≠ Absence of Waste</strong></h3>
<ul>
  <li><strong>Scope of Ethics Review</strong>: Ethical boards prioritize participant welfare, informed consent, and risk minimization, not the societal value or methodological rigor of the research. A study can be ethically sound but still wasteful if its scientific merit or practical relevance is low.</li>
  <li><strong>Funding Criteria</strong>: Funding bodies may prioritize technical feasibility or alignment with institutional goals over critical evaluation of a study’s potential to reduce knowledge gaps or improve outcomes.</li>
</ul>

<h3 id="3-moral-authority-to-critique">3. <strong>Moral Authority to Critique</strong></h3>
<ul>
  <li><strong>Utilitarian Perspective</strong>: The morality of research hinges on maximizing societal good. If resources could have produced greater benefit elsewhere (e.g., addressing understudied diseases), wasteful research is ethically questionable due to <strong>opportunity costs</strong>.</li>
  <li><strong>Deontological Ethics</strong>: Researchers have a duty to uphold principles like beneficence (advancing knowledge) and non-maleficence (avoiding harm from misallocated resources). Waste violates these duties by squandering finite resources.</li>
  <li><strong>Epistemic Responsibility</strong>: Researchers are stewards of collective knowledge. Studies failing to contribute meaningfully—even if technically compliant—betray this responsibility.</li>
</ul>

<h3 id="4-philosophical-frameworks-supporting-anti-waste-norms">4. <strong>Philosophical Frameworks Supporting Anti-Waste Norms</strong></h3>
<ul>
  <li><strong>Social Contract Theory</strong>: Research relies on public trust and resources. Waste undermines this contract by eroding confidence in science’s ability to address societal needs.</li>
  <li><strong>Virtue Ethics</strong>: Researchers should cultivate intellectual humility, rigor, and a commitment to the common good. Wasteful practices reflect vices like complacency or negligence.</li>
  <li><strong>Justice</strong>: Resources allocated to low-value research divert attention from marginalized communities or underfunded fields, perpetuating inequities.</li>
</ul>

<h3 id="5-counterarguments-and-nuances">5. <strong>Counterarguments and Nuances</strong></h3>
<ul>
  <li><strong>Unpredictability of Science</strong>: Some “wasteful” studies serendipitously yield breakthroughs. However, this does not justify poor prioritization; systemic waste remains a moral issue.</li>
  <li><strong>Subjectivity of Value</strong>: Determining what is “wasteful” can be contested. Solutions include participatory priority-setting (engaging stakeholders) and transparent evaluation frameworks.</li>
</ul>

<h3 id="6-conclusion">6. <strong>Conclusion</strong></h3>
<p>Research waste is a moral concern distinct from misconduct or ethical violations. It arises from failures in stewardship, prioritization, and epistemic responsibility. Philosophical principles provide a robust basis for critiquing such waste, emphasizing researchers’ obligations to maximize societal benefit, uphold trust, and address inequities. Thus, even compliant studies can—and should—be scrutinized for their contribution to the greater good.</p>

<hr />

<p>Date of inference: May 18, 2025 (UTC-4), via chat.deepseek.com</p>]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[User: I am doing a thesis on research waste, but I keep wondering: Is there such a thing as research waste? If the study in question received proper ethical review board approval, the principal investigator qualified for funding, and we assume no outright misconduct (e.g., no fabrication, falsification, plagiarism), do we have the moral authority to claim that the study should not have happened? Perhaps philosophers in the room could help me out.]]></summary></entry><entry><title type="html">AWARE at IHPME Research and Impact Day 2025</title><link href="https://researchwaste.info/2025/05/05/ihpme-research-and-impact-day" rel="alternate" type="text/html" title="AWARE at IHPME Research and Impact Day 2025" /><published>2025-05-05T00:00:00+00:00</published><updated>2025-05-05T00:00:00+00:00</updated><id>https://researchwaste.info/2025/05/05/ihpme-research-and-impact-day</id><content type="html" xml:base="https://researchwaste.info/2025/05/05/ihpme-research-and-impact-day"><![CDATA[<p><img src="/assets/media/ihpme_research_and_impact_day_2025_logo.png" alt="IHPME Research and Impact Day 2025 Logo" /></p>

<p>I am pleased to let everyone know that I am presenting the research work accomplished to date at the <a href="https://ihpme.utoronto.ca/event/research-impact-day-2025/">IHPME Research and Impact Day 2025</a>. This is a student-led event held annually at the Institute of Health Policy, Management and Evaluation (Dalla Lana School of Public Health) of the University of Toronto, which is also my primary affiliation.</p>

<h2 id="event-details">Event details</h2>

<p><strong>Topic: ResearchWaste.info: Raising awareness of avoidable waste in health research</strong></p>

<p>My oral presentation is included in the Global Health section scheduled for Wednesday May 7th at 11:30-11:45am EDT (UTC-4). Location: Toronto, Ontario, Canada.</p>

<p>📍 <a href="https://maps.app.goo.gl/44z3PxoKWzgf1emn8">Health Sciences Building</a>, 7th Floor, Room 734</p>

<h2 id="virtual-participation">Virtual participation</h2>

<p>Unfortunately, this year no virtual broadcast nor recording are planned. However, feel free to download my slide deck (licensed under <a href="https://creativecommons.org/licenses/by-sa/4.0/">CC BY-SA 4.0 International</a>):</p>

<p><a href="/assets/pptx/Pavel_Zhelnov_2025-05-07_1130-1145_IHPME_HSB_Room_734_v6.pptx">Slide Deck - PowerPoint</a></p>

<p><a href="/assets/pdf/Pavel_Zhelnov_2025-05-07_1130-1145_IHPME_HSB_Room_734_v6.pdf">Slide Deck - PDF</a></p>

<h2 id="call-for-feedback">Call for feedback</h2>

<p>The slide deck is quite novel and contains a few intriguing experiments (such as the first-of-a-kind self-evaluation of research waste), so I hope you enjoy it!</p>

<p>Have any feedback? Let me know on <a href="https://www.linkedin.com/in/drzhelnov">LinkedIn</a> or via this <a href="/contact/">feedback form</a>.</p>]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[]]></summary></entry><entry><title type="html">Fifty shades of health research</title><link href="https://researchwaste.info/2024/12/12/fifty-shades-of-research" rel="alternate" type="text/html" title="Fifty shades of health research" /><published>2025-03-14T02:47:00+00:00</published><updated>2025-03-14T02:47:00+00:00</updated><id>https://researchwaste.info/2024/12/12/fifty-shades-of-research</id><content type="html" xml:base="https://researchwaste.info/2024/12/12/fifty-shades-of-research"><![CDATA[<blockquote>
  <p>A version of this article was originally published in the University of Toronto’s <a href="https://mailchi.mp/913d9cc555c0/centre-for-global-health-march-2025-newsletter">Centre for Global Health Bulletin, March 2025 Newsletter</a>. All changes are tracked in the <a href="https://github.com/drzhelnov/aware/commits/main/_posts/2024-12-12-fifty-shades-of-research.md">version history on GitHub</a>.</p>
</blockquote>

<h2 id="summary">Summary</h2>

<p>What counts as <em>bad</em> health research? There is no single answer. This article presents (not fifty but) three distinct cases of controversial biomedical, clinical, and “meta” research and introduces a broad audience to the topic of research waste. Research waste refers to the inefficient, ineffective, or unintentionally harmful use of resources (e.g., financial, human, time, participant burden, or excess use of animals) at any level of the health research ecosystem.</p>

<h2 id="case-1-landmark-paper-retracted-over-images-suspicious-of-manipulation">Case 1: Landmark paper retracted over images suspicious of manipulation</h2>

<p>In June 2024, a scientific paper published 18 years ago was retracted (<a href="#ref-lesne_specific_2006">Lesné et al., 2006</a>). This paper is now considered one of the <a href="https://retractionwatch.com/the-retraction-watch-leaderboard/top-10-most-highly-cited-retracted-papers/">most influential papers ever retracted</a>. After <a href="https://pubpeer.com/publications/8FF7E6996524B73ACB4A9EF5C0AACF#">concerns were raised online</a> about the trustworthiness of the figures on which its conclusion was based, an online discussion and an <a href="https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-disease">investigation</a> by the journal ensued. In consequence, the authors <a href="https://doi.org/10.1038/s41586-024-07691-8">retracted</a> the paper.</p>

<p>This case was highly publicized by <em><a href="https://www.science.org/content/article/researchers-plan-retract-landmark-alzheimers-paper-containing-doctored-images">Science</a></em> and other media. The paper itself was cited <a href="https://retractionwatch.com/the-retraction-watch-leaderboard/top-10-most-highly-cited-retracted-papers/">over 2,300 times</a>, including more than 10 citations after the retraction note was published. One of the reasons for this study’s popularity is its landmark role in Alzheimer’s disease research: after years of failure to develop an effective Alzheimer’s medication, this study provided experimental evidence of a <a href="https://doi.org/10.1038/440284a">promising drug target</a>. Its retraction <a href="https://en.wikipedia.org/wiki/Sylvain_Lesn%C3%A9#Impact_on_Alzheimer's_research">cast a slight shadow</a> on the consequent research and translation efforts.</p>

<h2 id="case-2-five-hundred-excessive-deaths-in-patients-not-offered-an-effective-drug">Case 2: Five hundred excessive deaths in patients not offered an effective drug</h2>

<p>“Of more than 2000 redundant clinical trials on statins in patients with coronary artery disease… an extra 3000 [major adverse cardiac events], including nearly 600 deaths, were experienced by participants not treated with statins in these trials.”</p>

<p>This is the conclusion reached after <a href="https://doi.org/10.1136/bmj.n48">investigating the aftermath</a> of a clinical cardiology practice guideline introduced in 2007 in China. This guideline included a strong recommendation, based on high-quality evidence, for administering a statin medication to patients with two common heart diseases: stable angina pectoris or acute coronary syndrome. It was then logical to assume, the investigators argued, that any new trials conducted after that point (plus a one-year lag to account for the guideline adoption) were to be considered redundant, and 3470 people harmed.</p>

<p>The results of this investigation were published in the reputable <em>British Medical Journal (BMJ)</em> journal back in 2021 (<a href="#ref-jia_effect_2021">Jia et al., 2021</a>). Almost four years after its publication, it has not been widely publicized. The publication’s <a href="https://www.altmetric.com/details/99262997">Altmetric profile</a> shows that it was only ever picked up by two news outlets, one blog, and 53 social media posts. It has also received only <a href="https://openalex.org/works?filter=cites%3Aw3129053163">18 academic citations</a>.</p>

<h2 id="case-3-the-false-promise-of-meta-research">Case 3: The false promise of meta-research</h2>

<p>A recently published <a href="https://doi.org/10.7717/peerj.18466">review of methods</a> for assessing research “waste” is not among the 18 papers that cited the statin trials study. Research waste includes practices that are known to be controversial but are not broadly condemned as <a href="https://allea.org/code-of-conduct/">questionable (unacceptable)</a> or as alleged misconduct (<a href="#ref-rosengaard_five_2024">Rosengaard et al., 2024a</a>). Upon examination, the reason why the statin trials study was missed was because of a slight difference in the wording used in the study abstract and the review’s search strategy. This is despite the rigorous design and state-of-the-art methods employed by the review authors (<a href="#ref-rosengaard_several_2024">Rosengaard et al., 2024b</a>).</p>

<p>Evidence syntheses of health research are designed to be “the way that academics bring together knowledge from across multiple studies into a whole, to present the state of current understanding about a given area” (<a href="#ref-thomas_methods_2024">Thomas, 2024</a>). There are multiple examples of how the field does not fully deliver its promise. A recent finding was that <a href="https://doi.org/10.1016/j.jclinepi.2023.111229">78% of systematic reviews do not have a reproducible search strategy</a>, considered to be a key feature of this kind of meta-research study (<a href="#ref-rethlefsen_systematic_2024">Rethlefsen et al., 2024</a>). Another estimate contends that <a href="https://doi.org/10.1111/1468-0009.12210">97% of systematic reviews either do not have adequate methods or are clinically useless</a> (<a href="#ref-ioannidis_mass_2016">Ioannidis, 2016</a>). There is <a href="https://doi.org/10.1097/XEB.0000000000000201">not enough unanimity</a> even on the preferred terminology to denote meta-research itself, let alone on how to collaborate efficiently (<a href="#ref-puljak_methodological_2019">Puljak, 2019</a>).</p>

<h2 id="aware-of-research-waste">AWARE of research waste</h2>

<p>This article presented three distinct cases of health research that can, ostensibly, be called “bad.” The cases range from the darkest shades (Case 1: a retracted article due to alleged misconduct) through a well-declared gray zone (Case 2: research explicitly called redundant in a meta-research study) or even an area genuinely challenging to categorize on a black and white spectrum (Case 3: integral challenges within meta-research itself).</p>

<p>The difference, however, seems to be primarily in the degree of community consensus toward the label (misconduct vs. waste vs. “challenges”), not necessarily the impacts of the discussed research. For example, the largely unnoticed Case 2 provides evidence for well-documented, and drastic, negative health outcomes whereas, for the widely condemned and retracted Case 1, the direct health impacts are more elusive.</p>

<p>A broader scholarly debate questions whether a research work should be evaluated based on its “quality” in and of itself or based on its “impacts” on the world. A notable discussion happened around a 2022 initiative called the <a href="https://coara.eu/">Coalition for Advancing Research Assessment (CoARA)</a>. The coalition calls for wider adoption of peer review in research assessment, in opposition to publication-based metrics. This initiative received <a href="https://doi.org/10.1093/reseval/rvae021">strong pushback</a> from the president of the International Society for Scientometrics and Infometrics (ISSI) (<a href="#ref-abramo_forced_2024">Abramo, 2024</a>).</p>

<p>It is clear that no unanimous position exists in the academic community as to what exactly constitutes bad health research. Complete clarity about what we mean by research waste and how we measure it is urgently needed to develop evidence-based strategies for easing its insidious pressure on health care decision-makers, providers, and patients globally.</p>

<p>Our project, called <a href="https://researchwaste.info/about/">Avoidable WAste in health REsearch (AWARE)</a>, aims to look more into this.</p>

<h2 id="acknowledgments">Acknowledgments</h2>

<p>I would like to thank Erica Di Ruggiero and Michelle Christian for their helpful feedback on an earlier version of this article, the Scientometrics Centre at the HSE University for their informative news feed, my supervisor Andrea Tricco for the opportunities to study this topic, and the many other colleagues who shared their insights about research waste over the past 2 years.</p>

<h2 id="references">References</h2>

<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0" line-spacing="2">

  <div id="ref-abramo_forced_2024" class="csl-entry">

    <p>Abramo, G. (2024). The forced battle between peer-review and scientometric research assessment: Why the CoARA initiative is unsound. <em>Research Evaluation</em>, rvae021. <a href="https://doi.org/10.1093/reseval/rvae021">https://doi.org/10.1093/reseval/rvae021</a></p>

  </div>

  <div id="ref-ioannidis_mass_2016" class="csl-entry">

    <p>Ioannidis, J. P. A. (2016). The mass production of redundant, misleading, and conflicted systematic reviews and meta‐analyses. <em>The Milbank Quarterly</em>, <em>94</em>(3), 485–514. <a href="https://doi.org/10.1111/1468-0009.12210">https://doi.org/10.1111/1468-0009.12210</a></p>

  </div>

  <div id="ref-jia_effect_2021" class="csl-entry">

    <p>Jia, Y., Wen, J., Qureshi, R., Ehrhardt, S., Celentano, D. D., Wei, X., Rosman, L., Wen, Y., &amp; Robinson, K. A. (2021). Effect of redundant clinical trials from mainland China evaluating statins in patients with coronary artery disease: Cross sectional study. <em>BMJ</em>, n48. <a href="https://doi.org/10.1136/bmj.n48">https://doi.org/10.1136/bmj.n48</a></p>

  </div>

  <div id="ref-lesne_specific_2006" class="csl-entry">

    <p>Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., &amp; Ashe, K. H. (2006). RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory. <em>Nature</em>, <em>440</em>(7082), 352–357. <a href="https://doi.org/10.1038/nature04533">https://doi.org/10.1038/nature04533</a></p>

  </div>

  <div id="ref-puljak_methodological_2019" class="csl-entry">

    <p>Puljak, L. (2019). Methodological research: Open questions, the need for ’research on research’ and its implications for evidence-based health care and reducing research waste. <em>International Journal of Evidence-Based Healthcare</em>, <em>17</em>(3), 145–146. <a href="https://doi.org/10.1097/XEB.0000000000000201">https://doi.org/10.1097/XEB.0000000000000201</a></p>

  </div>

  <div id="ref-rethlefsen_systematic_2024" class="csl-entry">

    <p>Rethlefsen, M. L., Brigham, T. J., Price, C., Moher, D., Bouter, L. M., Kirkham, J. J., Schroter, S., &amp; Zeegers, M. P. (2024). Systematic review search strategies are poorly reported and not reproducible: A cross-sectional metaresearch study. <em>Journal of Clinical Epidemiology</em>, <em>166</em>, 111229. <a href="https://doi.org/10.1016/j.jclinepi.2023.111229">https://doi.org/10.1016/j.jclinepi.2023.111229</a></p>

  </div>

  <div id="ref-rosengaard_five_2024" class="csl-entry">

    <p>Rosengaard, L. O., Andersen, M. Z., Rosenberg, J., &amp; Fonnes, S. (2024a). Five aspects of research waste in biomedicine: A scoping review. <em>Journal of Evidence-Based Medicine</em>, jebm.12616. <a href="https://doi.org/10.1111/jebm.12616">https://doi.org/10.1111/jebm.12616</a></p>

  </div>

  <div id="ref-rosengaard_several_2024" class="csl-entry">

    <p>Rosengaard, L. O., Andersen, M. Z., Rosenberg, J., &amp; Fonnes, S. (2024b). Several methods for assessing research waste in reviews with a systematic search: A scoping review. <em>PeerJ</em>, <em>12</em>, e18466. <a href="https://doi.org/10.7717/peerj.18466">https://doi.org/10.7717/peerj.18466</a></p>

  </div>

  <div id="ref-thomas_methods_2024" class="csl-entry">

    <p>Thomas, J. (2024). Methods development in evidence synthesis: A dialogue between science and society. In A. Oancea, G. E. Derrick, N. Nuseibeh, &amp; X. Xu (Eds.), <em>Handbook of Meta-Research</em> (pp. 146–158). Edward Elgar Publishing. <a href="https://doi.org/10.4337/9781839105722.00020">https://doi.org/10.4337/9781839105722.00020</a></p>

  </div>

</div>]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[A version of this article was originally published in the University of Toronto’s Centre for Global Health Bulletin, March 2025 Newsletter. All changes are tracked in the version history on GitHub.]]></summary></entry><entry><title type="html">Research waste—article by STORM AI</title><link href="https://researchwaste.info/2024/11/05/research-waste-storm.html" rel="alternate" type="text/html" title="Research waste—article by STORM AI" /><published>2024-11-05T00:00:00+00:00</published><updated>2024-11-05T00:00:00+00:00</updated><id>https://researchwaste.info/2024/11/05/research-waste-storm</id><content type="html" xml:base="https://researchwaste.info/2024/11/05/research-waste-storm.html"><![CDATA[<p>Check <a href="https://storm.genie.stanford.edu/article/250657">https://storm.genie.stanford.edu/article/250657</a> for more details<br />
Stanford University Open Virtual Assistant Lab<br />
The generated report can make mistakes.<br />
Please consider checking important information.<br />
The generated content does not represent the developer’s viewpoint.</p>

<p><a href="/assets/pdf/research_waste_storm_2024-11-05.pdf">Show as PDF</a></p>

<h1 id="summary">Summary</h1>

<p>Research waste refers to the inefficiencies and misallocation of resources within the scientific research process, particularly in biomedical and ecological fields. Estimates indicate that up to 85% of research funding may be wasted due to various factors, including inadequate study design, poor question selection, and ineffective reporting practices.<a href="https://guides.hsict.library.utoronto.ca/c.php?g=707166&amp;p=5037232">[1]</a><a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a></p>

<p> This pervasive issue not only undermines the integrity of scientific inquiry but also has profound economic and social implications, leading to significant financial losses and hindered advancements in public health and environmental sustainability.<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a><a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a></p>

<p> The classification of research waste can be divided into four primary categories: Question Selection, Study Design, Publication, and Reporting.<a href="https://guides.hsict.library.utoronto.ca/c.php?g=707166&amp;p=5037232">[1]</a><a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a></p>

<p> Each category highlights different stages where inefficiencies can occur. For instance, poor planning may result in redundant studies, while flawed methodologies can compromise the validity of findings.<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a> Additionally, many studies fail to reach publication, a phenomenon known as publication bias, which skews the scientific literature and obscures valuable insights.<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a> Underreporting of results further complicates the landscape, limiting the reproducibility and utility of research outputs.<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a> Controversies surrounding research waste have sparked calls for reform across the scientific community. Critics argue that systemic changes are necessary to enhance the efficiency of research practices, including the adoption of open science initiatives and improved ethical oversight by research committees.<a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a><a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a></p>

<p> These reforms aim to foster transparency, promote collaboration, and ultimately ensure that research efforts contribute meaningfully to scientific knowledge and societal well-being. In summary, addressing research waste is critical for maximizing the value of research investments and improving outcomes in both health and environmental fields. The commitment to reforming research practices not only stands to enhance the integrity and effectiveness of scientific inquiry but also to safeguard public trust in research as a tool for social progress.<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a><a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a></p>

<h1 id="types-of-research-waste">Types of Research Waste</h1>

<p>Research waste in the biomedical field has been categorized into various types that contribute to inefficiencies in the research process. According to a study by Chalmers and Glasziou, it is estimated that 85% of funds allocated to research are wasted due to inadequate production and reporting of results<a href="https://guides.hsict.library.utoronto.ca/c.php?g=707166&amp;p=5037232">[1]</a>. The different types of research waste can be broadly divided into four primary categories: Question Selection, Study Design, Publication, and Reporting.</p>

<h2 id="methodological-research-waste">Methodological Research Waste</h2>

<p>Methodological research waste includes flaws in the study design, conduct, or analysis of research projects. A scoping review categorized research waste into five aspects, referred to as MINUS waste: methodological, invisible, negligible, underreported, and structural<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a>. Methodological waste constitutes a significant portion, with over half of the reviewed reports indicating issues in study design that hinder the reliability and validity of findings. These methodological flaws can lead to misleading conclusions and ultimately diminish the overall value of research outputs<a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a>.</p>

<h2 id="invisible-research-waste">Invisible Research Waste</h2>

<p>Invisible research waste pertains to research that remains unpublished or is discontinued before completion, leading to a loss of valuable data and insights. This aspect of waste also includes the lack of data-sharing among researchers, which can further exacerbate the inefficiencies in the research ecosystem. According to the aforementioned scoping review, this category highlights the importance of transparency and dissemination in maximizing the value of research efforts<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a>.</p>

<h2 id="negligible-research-waste">Negligible Research Waste</h2>

<p>Negligible research waste primarily arises from unnecessary repetitions in studies, often due to the absence of thorough literature reviews prior to conducting new trials. This type of waste can dilute the scientific rigor of a field, as it leads to overlapping findings that do not contribute additional knowledge<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a>. Addressing this issue requires better planning and awareness of existing research to ensure that new studies are genuinely novel and necessary.</p>

<h2 id="underreported-research-waste">Underreported Research Waste</h2>

<p>Underreported research waste involves poor reporting practices, resulting in incomplete or unclear findings that can mislead future research and policy decisions. This aspect of waste emphasizes the need for adherence to established reporting standards to enhance the clarity and utility of research outputs<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a><a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. Inadequate reporting can obscure significant results, thereby limiting their impact on the scientific community and public health initiatives.</p>

<h2 id="structural-research-waste">Structural Research Waste</h2>

<p>Finally, structural research waste arises from systemic issues such as inadequate management, collaboration, and prioritization of research efforts. These inefficiencies can result in underpowered studies and a lack of coordination among researchers, undermining the potential benefits of collective research efforts<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. Addressing these structural barriers is essential for improving the overall efficiency and effectiveness of research practices.</p>

<h1 id="causes-of-research-waste">Causes of Research Waste</h1>

<p>Research waste is a significant issue across various scientific fields, particularly in biomedicine and ecology, where inefficiencies can lead to substantial resource loss. Several factors contribute to this waste, which can be categorized into distinct types.</p>

<h2 id="categories-of-research-waste">Categories of Research Waste</h2>

<p>Research waste can be broadly divided into four primary categories: Question Selection, Study Design, Publication, and Reporting<a href="https://guides.hsict.library.utoronto.ca/c.php?g=707166&amp;p=5037232">[1]</a>. Each of these categories reflects different stages of the research process where inefficiencies can arise.</p>

<h3 id="question-selection">Question Selection</h3>

<p>Poor planning and prioritization of research questions often lead to duplicative studies that fail to advance scientific understanding<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. Researchers may choose questions that are either redundant or of low importance, thereby squandering resources that could be allocated to more meaningful inquiries<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>.</p>

<h3 id="study-design">Study Design</h3>

<p>Inappropriate study design is another major contributor to research waste. Flaws in the methodology can result in uninformative or misleading results. Common issues include inadequate sample sizes, lack of control groups, and improper statistical analyses<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. These design shortcomings not only affect the validity of individual studies but can also misguide future research directions.</p>

<h3 id="publication">Publication</h3>

<p>The publication process can also foster waste. Many studies fail to reach publication due to perceived lack of novelty or significance, despite potentially valuable findings<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a>. This publication bias skews the scientific literature, leaving important results unpublished and unrecognized<a href="https://guides.hsict.library.utoronto.ca/c.php?g=707166&amp;p=5037232">[1]</a>. Moreover, the increasing volume of research articles may overwhelm researchers, making it challenging to stay current and thus potentially leading to redundant studies<a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a>.</p>

<h3 id="reporting">Reporting</h3>

<p>Finally, the way research is reported plays a critical role in research waste. Inadequate or unclear reporting can hinder the reproducibility of studies, which is essential for validating findings and advancing knowledge<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. Researchers may fail to share their data or methodologies adequately, limiting the ability of others to build upon their work. Additionally, a lack of coordination among studies within the same institution can undermine participant recruitment and result in terminated or underpowered studies<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>.</p>

<h2 id="implications-of-research-waste">Implications of Research Waste</h2>

<p>The implications of research waste are profound. It is estimated that a staggering 85% of research investment may not contribute meaningfully to scientific advancement or social good<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a><a href="https://www.bmj.com/content/363/bmj.k4645">[5]</a>. As ecological and biomedical challenges grow, addressing the causes of research waste becomes increasingly critical for the efficient use of resources and the enhancement of research value<a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a>.</p>

<h1 id="impacts-of-research-waste">Impacts of Research Waste</h1>

<p>Research waste has significant implications across various scientific fields, particularly in biomedical and ecological research. It not only undermines the integrity of the research process but also leads to considerable economic and social costs.</p>

<h2 id="economic-consequences">Economic Consequences</h2>

<p>The economic impact of research waste is substantial. A study by Chalmers and Glasziou (2009) estimated that up to 85% of funding in biomedical research is wasted due to inefficiencies in production and reporting<a href="https://guides.hsict.library.utoronto.ca/c.php?g=707166&amp;p=5037232">[1]</a>. In ecological research, it has been found that only 11-18% of conducted studies reach their full informative value<a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a>. This indicates a severe loss of resources, as funds spent on ineffective research could have been directed towards more valuable scientific endeavors. Additionally, the absence of FAIR (Findable, Accessible, Interoperable, and Reusable) data practices has been estimated to cost the European economy at least €10.2 billion annually<a href="https://projectopen.io/stories/">[6]</a>.</p>

<h2 id="social-implications">Social Implications</h2>

<p>The social ramifications of research waste are equally concerning. Studies lacking sufficient scientific and social value expose participants to risks without advancing scientific understanding<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. Research ethics committees could play a critical role in minimizing waste by evaluating the potential value of studies before granting approval. However, they face challenges, including insufficient scientific expertise and time to conduct thorough evidence reviews<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. This situation highlights the need for collaboration among funding agencies, researchers, and ethics committees to ensure that studies contribute meaningfully to scientific knowledge and public welfare.</p>

<h2 id="influence-on-scientific-quality">Influence on Scientific Quality</h2>

<p>The pervasive issue of research waste also threatens the overall quality of scientific output. Historical predictions have suggested that the exponential growth of research could lead to a decline in quality control within the scientific community<a href="https://en.wikipedia.org/wiki/Replication_crisis">[7]</a>. Concerns regarding commodification and the outsourcing of research to profit-driven entities further exacerbate this decline, indicating a need for systemic changes to uphold the integrity of scientific research.</p>

<h1 id="strategies-to-reduce-research-waste">Strategies to Reduce Research Waste</h1>

<h2 id="understanding-research-waste">Understanding Research Waste</h2>

<p>Research waste is a significant issue across various scientific disciplines, particularly in biomedical and ecological research. Estimates suggest that up to 85% of research funding may be wasted due to factors such as inadequate study design, poor question selection, and ineffective reporting practices<a href="https://pubmed.ncbi.nlm.nih.gov/24411644/">[8]</a><a href="https://guides.hsict.library.utoronto.ca/c.php?g=707166&amp;p=5037232">[1]</a>. Recognizing and addressing these inefficiencies is critical to maximizing the value of research and ensuring that resources are used effectively.</p>

<h2 id="frameworks-for-improvement">Frameworks for Improvement</h2>

<p>To combat research waste, several frameworks and guidelines have been proposed. For instance, the INQUIRE framework offers a structured approach that can be operationalized at multiple levels, including the study level, to assess and improve research quality<a href="https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002580">[9]</a>. This framework can serve as a common language among stakeholders, fostering discussions on how to enhance research practices and reduce waste across academia and other sectors.</p>

<h2 id="enhancing-research-design">Enhancing Research Design</h2>

<p>A robust research design is essential for minimizing waste. Flaws in the design phase can lead to unreliable results and decreased overall value<a href="https://libguides.usc.edu/writingguide/designflaws">[10]</a>. Researchers are encouraged to invest time in developing thorough research plans that clearly outline objectives, methodologies, and potential limitations. By doing so, they can enhance the quality and reliability of their findings.</p>

<h2 id="ethical-oversight">Ethical Oversight</h2>

<p>Research ethics committees play a crucial role in minimizing waste by evaluating proposed studies for their potential value. Salman et al. suggest that these committees could take a more proactive approach by approving or rejecting studies based on their perceived utility<a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. However, there are challenges to implementing this strategy, such as the need for clear criteria to assess the potential wastefulness of research projects.</p>

<h2 id="open-research-practices">Open Research Practices</h2>

<p>Adopting open research practices, including open data initiatives and open peer review, is another strategy for reducing waste. Sharing data and methodologies publicly can enhance transparency, facilitate reproducibility, and encourage collaboration within the research community<a href="https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-021-01304-y">[11]</a>. Such practices can also help mitigate the replication crisis by making it easier for other researchers to validate findings and build upon existing work.</p>

<h2 id="collaboration-and-capacity-building">Collaboration and Capacity Building</h2>

<p>Investment in research infrastructure and collaboration among stakeholders is vital for improving research uptake and reducing waste, especially in low- and middle-income countries (LMICs)<a href="https://health-policy-systems.biomedcentral.com/articles/10.1186/s12961-023-01084-5">[12]</a>. Engaging diverse stakeholders can foster partnerships that promote the use of research findings in policymaking and support capacity-building efforts. This collaborative approach can help address structural barriers that hinder effective research translation.</p>

<h1 id="case-studies">Case Studies</h1>

<h2 id="overview-of-research-waste-in-different-fields">Overview of Research Waste in Different Fields</h2>

<p>Research inefficiencies, often labeled as “research waste,” can lead to significant financial losses and hinder scientific progress. Various studies illustrate the extent of waste across different research disciplines. For instance, a 2009 study by Chalmers and Glasziou revealed that as much as 85% of research funding in the biomedical field is squandered due to poor production and reporting practices<a href="https://guides.hsict.library.utoronto.ca/c.php?g=707166&amp;p=5037232">[1]</a><a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. This alarming statistic underscores the need for a critical examination of research methodologies and their impacts on the scientific community.</p>

<h2 id="methodological-studies">Methodological Studies</h2>

<p>Methodological studies serve as a vital tool in identifying and addressing research waste. These studies report on the design, conduct, analysis, or reporting of both primary and secondary research, thereby allowing for an appraisal of the quality and consistency of health research<a href="https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-020-01107-7">[13]</a>. Analyzing specific fields, journals, and geographical regions can highlight systemic issues contributing to waste. For example, researchers have investigated the adherence to reporting standards, such as the CONSORT guidelines in randomized trials, which shed light on how reporting practices influence the integrity of scientific findings<a href="https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-020-01107-7">[13]</a>.</p>

<h2 id="case-studies-in-ecological-research">Case Studies in Ecological Research</h2>

<p>One of the more recent investigations into research waste focused on ecological studies, which are crucial given their relevance to global sustainability challenges. This study estimated that only 11-18% of ecological research achieves its full informative value<a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a>. By conducting a literature review and meta-analysis, researchers were able to quantify waste components and emphasize the necessity for improved research practices in ecology.</p>

<h2 id="open-science-initiatives">Open Science Initiatives</h2>

<p>Open science initiatives have emerged as a pivotal movement aimed at enhancing the transparency, accessibility, and reproducibility of research practices. By embracing the principles of openness, these initiatives seek to democratize knowledge, encourage collaboration, and reduce research waste in various scientific fields.</p>

<h3 id="objectives-of-open-science-initiatives">Objectives of Open Science Initiatives</h3>

<p>Open science aims to make research outputs, including data, methodologies, and publications, more readily available to the public and the scientific community. The fundamental goals include improving accessibility to scientific knowledge, fostering collaboration among researchers, and enhancing public engagement with scientific research. This alignment with the broader goals of societal benefit has driven the rapid adoption of open science practices over the past decade<a href="https://sciformat.com/blog/case-studies-in-open-science/">[14]</a><a href="https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000576">[15]</a>.</p>

<h3 id="impact-on-research-waste">Impact on Research Waste</h3>

<p>One of the critical challenges that open science initiatives address is the issue of research waste. Evidence from biomedical research has indicated that a significant portion of research findings is avoidably wasted due to inefficiencies in study design, reporting, and dissemination<a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a><a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a>. Open science practices, such as preregistration of studies and sharing raw data and methodologies, have been proposed as solutions to mitigate this waste by promoting better planning and transparency in research processes<a href="https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-021-01304-y">[11]</a><a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a>.</p>

<h3 id="collaborative-frameworks-and-policies">Collaborative Frameworks and Policies</h3>

<p>The advancement of open science policies and mandates by governments, funding agencies, and academic institutions plays a crucial role in this movement. As these policies become more comprehensive—encompassing open access to publications, open data, and open methodologies—they are expected to drive a more universal commitment to the principles of open science<a href="https://sciformat.com/blog/case-studies-in-open-science/">[14]</a>. Advocacy organizations like SPARC and Open Knowledge International have been instrumental in promoting these policies and raising awareness of the benefits of open science practices<a href="https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000576">[15]</a>.</p>

<h3 id="lessons-learned-from-success-stories">Lessons Learned from Success Stories</h3>

<p>The exploration of successful open science initiatives reveals several key lessons for the scientific community. These initiatives demonstrate the importance of fostering a culture of transparency and collaboration, which can lead to diverse, just, and sustainable research outcomes. Additionally, the journey of these initiatives underscores the necessity for continued commitment and innovation in order to fully realize the potential of open science in advancing research and societal contributions<a href="https://sciformat.com/blog/case-studies-in-open-science/">[14]</a><a href="https://projectopen.io/stories/">[6]</a>.</p>

<h2 id="lessons-learned">Lessons Learned</h2>

<p>Through the evaluation of various research practices, several key lessons have emerged. It is essential for institutions to support changes in reward and incentive structures that prioritize responsible research. Engaging researchers, clinicians, and administrators through both top-down and bottom-up approaches can foster a community commitment to reducing waste<a href="https://www.scijournal.org/articles/best-open-science-initiatives-and-practices">[16]</a>. This holistic engagement is critical in building a sustainable research culture that values transparency and integrity in scientific inquiry.</p>

<h1 id="open-science-initiatives-1">Open Science Initiatives</h1>

<p>Open science initiatives have emerged as a pivotal movement aimed at enhancing the transparency, accessibility, and reproducibility of research practices. By embracing the principles of openness, these initiatives seek to democratize knowledge, encourage collaboration, and reduce research waste in various scientific fields.</p>

<h2 id="objectives-of-open-science-initiatives-1">Objectives of Open Science Initiatives</h2>

<p>Open science aims to make research outputs, including data, methodologies, and publications, more readily available to the public and the scientific community. The fundamental goals include improving accessibility to scientific knowledge, fostering collaboration among researchers, and enhancing public engagement with scientific research. This alignment with the broader goals of societal benefit has driven the rapid adoption of open science practices over the past decade<a href="https://sciformat.com/blog/case-studies-in-open-science/">[14]</a><a href="https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000576">[15]</a>.</p>

<h2 id="impact-on-research-waste-1">Impact on Research Waste</h2>

<p>One of the critical challenges that open science initiatives address is the issue of research waste. Evidence from biomedical research has indicated that a significant portion of research findings is avoidably wasted due to inefficiencies in study design, reporting, and dissemination<a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a><a href="https://pubmed.ncbi.nlm.nih.gov/35864230/">[3]</a>. Open science practices, such as preregistration of studies and sharing raw data and methodologies, have been proposed as solutions to mitigate this waste by promoting better planning and transparency in research processes<a href="https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-021-01304-y">[11]</a><a href="https://bioethics.hms.harvard.edu/journal/irb-research-waste">[4]</a>.</p>

<h2 id="collaborative-frameworks-and-policies-1">Collaborative Frameworks and Policies</h2>

<p>The advancement of open science policies and mandates by governments, funding agencies, and academic institutions plays a crucial role in this movement. As these policies become more comprehensive—encompassing open access to publications, open data, and open methodologies—they are expected to drive a more universal commitment to the principles of open science<a href="https://sciformat.com/blog/case-studies-in-open-science/">[14]</a>. Advocacy organizations like SPARC and Open Knowledge International have been instrumental in promoting these policies and raising awareness of the benefits of open science practices<a href="https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3000576">[15]</a>.</p>

<h2 id="lessons-learned-from-success-stories-1">Lessons Learned from Success Stories</h2>

<p>The exploration of successful open science initiatives reveals several key lessons for the scientific community. These initiatives demonstrate the importance of fostering a culture of transparency and collaboration, which can lead to diverse, just, and sustainable research outcomes. Additionally, the journey of these initiatives underscores the necessity for continued commitment and innovation in order to fully realize the potential of open science in advancing research and societal contributions<a href="https://sciformat.com/blog/case-studies-in-open-science/">[14]</a><a href="https://projectopen.io/stories/">[6]</a>.</p>

<h1 id="influence-on-policy-and-funding">Influence on Policy and Funding</h1>

<h2 id="funding-sources-and-research-outcomes">Funding Sources and Research Outcomes</h2>

<p>The source of funding for research plays a critical role in determining the quality and integrity of the findings. Some studies suggest that industry-funded research may report more favorable outcomes compared to non-industry-funded studies, potentially due to conflicts of interest inherent in such funding arrangements. For instance, Kaiser et al. found that while the reporting quality of obesity and nutrition randomized trials was comparable regardless of funding source, other research, such as that by Thomas et al., indicated that industry-funded studies had better reporting quality in long-term weight loss trials<a href="https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-020-01107-7">[13]</a>. Furthermore, Kan et al. identified a strong correlation between industry funding and the likelihood of trials reporting significant positive outcomes, a finding echoed by a Cochrane Methodology Review by Hansen et al.<a href="https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-020-01107-7">[13]</a>.</p>

<h2 id="importance-of-transparency-in-funding">Importance of Transparency in Funding</h2>

<p>Transparency in research funding is crucial for maintaining the integrity of scientific inquiry. Many journals require funding statements, although this practice is not universally adopted. Ensuring that all research publications include detailed funding statements can promote transparency and foster a better understanding of the relationship between funding sources and research outputs. This transparency may also facilitate future meta-research on funding allocation and its effects on research quality<a href="https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3001949">[17]</a>.</p>

<h2 id="stakeholder-engagement-in-policymaking">Stakeholder Engagement in Policymaking</h2>

<p>The active engagement of stakeholders, including funders, community organizations, and local leaders, is essential for effective research implementation and policy development, particularly in low- and middle-income countries (LMICs). By involving these stakeholders from the inception of research projects, researchers can better align their work with local needs, foster collaboration, and enhance the uptake of evidence for policymaking<a href="https://health-policy-systems.biomedcentral.com/articles/10.1186/s12961-023-01084-5">[12]</a>. Despite the complexities of the bureaucratic environments in LMICs, establishing strong partnerships and communication channels among stakeholders can mitigate barriers to evidence utilization and improve health policy outcomes.</p>

<h2 id="challenges-to-evidence-utilization">Challenges to Evidence Utilization</h2>

<p>A significant portion of research resources is wasted due to various barriers, including poor access to high-quality research, inadequate timeliness of evidence delivery, and misaligned priorities between researchers and policymakers. According to the World Health Organization (WHO), implementing evidence-informed decision-making is vital for enhancing the effectiveness and equity of health policies. However, many decision-makers do not receive timely access to relevant research, leading to inefficient use of resources<a href="https://health-policy-systems.biomedcentral.com/articles/10.1186/s12961-023-01084-5">[12]</a><a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. To address these challenges, building strong networks and relationships among stakeholders is paramount. Collaboration among researchers, policymakers, and community representatives can facilitate the effective communication of research findings and foster a culture of evidence-informed policymaking<a href="https://i2insights.org/2019/05/07/research-influencing-policy/">[18]</a><a href="https://pubmed.ncbi.nlm.nih.gov/38798014/">[2]</a>. By focusing on clear communication strategies and fostering stakeholder engagement, researchers can increase the impact of their work on public policy, ensuring that it is rooted in the best available evidence<a href="https://i2insights.org/2019/05/07/research-influencing-policy/">[18]</a>.</p>]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[Check https://storm.genie.stanford.edu/article/250657 for more details Stanford University Open Virtual Assistant Lab The generated report can make mistakes. Please consider checking important information. The generated content does not represent the developer’s viewpoint.]]></summary></entry><entry><title type="html">85% podcast—Episode 1</title><link href="https://researchwaste.info/2024/09/21/85-percent-podcast-e1.html" rel="alternate" type="text/html" title="85% podcast—Episode 1" /><published>2024-09-21T00:00:00+00:00</published><updated>2024-09-21T00:00:00+00:00</updated><id>https://researchwaste.info/2024/09/21/85-percent-podcast-e1</id><content type="html" xml:base="https://researchwaste.info/2024/09/21/85-percent-podcast-e1.html"><![CDATA[<p>Oh, nothing unusual—just a robot talking to itself about AWARE.</p>

<iframe src="https://podcasters.spotify.com/pod/show/researchwaste/embed/episodes/85--Ep--1-e2olues" height="102px" width="400px" frameborder="0" scrolling="no"></iframe>

<p>It’s been over 2 months since the launch of <a href="https://researchwaste.info">researchwaste.info</a>, and I have been fortunate to receive tons of very helpful feedback, for which I am very thankful.</p>

<p>While I am revising the proposal, the first episode of my <a href="https://podcasters.spotify.com/pod/show/researchwaste">85% podcast</a> is a sneak peek of what’s to come. This robotic podcast has been generated with <a href="https://notebooklm.google.com/">NotebookLM</a> from the application package I am currently drafting to apply for <a href="https://cihr-irsc.gc.ca/e/50513.html">Canadian Institutes of Health Research funding</a>. Wish me luck!</p>

<p><i class="fa fa-youtube-play" aria-hidden="true"></i> <a href="https://www.youtube.com/watch?v=U5gana9yOJ0">Watch on YouTube</a></p>

<p><i class="fa fa-spotify" aria-hidden="true"></i> <a href="https://open.spotify.com/show/6mJg3B7mCvDKQg7JVl8TOp">Listen on Spotify</a></p>

<p><i class="fa fa-amazon" aria-hidden="true"></i> <a href="https://music.amazon.com/podcasts/52a3356c-2f07-4a58-ac55-04223d562bd5/85">Listen on Amazon Music</a></p>

<p><i class="fa fa-apple" aria-hidden="true"></i> <a href="https://podcasts.apple.com/us/podcast/85/id1769756366">Listen on Apple Podcasts</a></p>

<p><i class="fa fa-rss-square" aria-hidden="true"></i> <a href="https://anchor.fm/s/fb52f50c/podcast/rss">Podcast RSS</a></p>

<p><i class="fa fa-music" aria-hidden="true"></i> <a href="/assets/media/85_percent_e1_en.mp3">Download MP3 audio file</a></p>

<p>Below you will find a transcript of this episode (AI-generated of course! Again, thanks to Google):</p>

<hr />
<p><strong>Host:</strong> We put so much trust really into health research, right? New treatments, therapies, cures, it all comes back to research. But, um, what if I told you that a huge amount of this research might be totally wasted?</p>

<p><strong>Guest:</strong> Yeah, unfortunately, that’s true. There are studies that suggest that up to 85%, can you believe that? 85% of health research is basically useless. We’re talking billions of dollars, countless hours, all for very little gain.</p>

<p><strong>Host:</strong> Okay, hold on. Let’s break that down. Billions of dollars wasted. That’s insane! But what do we actually mean by “wasted” research? It’s not always about bad research or fraudulent studies, is it?</p>

<p><strong>Guest:</strong> No, you’re right. Outright fraud is a problem, don’t get me wrong, but a lot of this waste comes from less obvious but just as important issues. Things like studies that are poorly designed or ones that just repeat what we already know, or even research that’s asking questions nobody’s asking.</p>

<p><strong>Host:</strong> So, it’s like what? Building this high-tech bridge, but forgetting to check if anyone even needs to cross the river?</p>

<p><strong>Guest:</strong> Exactly. And the thing is this isn’t just some abstract academic problem. This impacts everyone. You, me, everyone we know. Think about it. Breakthroughs in treating diseases, maybe even finding cures. Those are being stalled because of this bottleneck of wasted research, and it also means that some of the treatments we rely on right now, might not even be as good as they could be, you know?</p>

<p><strong>Host:</strong> It’s kind of scary when you put it like that. Those delays in medical advancements all because of research that leads to dead ends. It makes you think. What really got me about Pavel’s story was how he was driven to find a solution after seeing firsthand the human cost of all this wasted research. You can really feel that passion, that drive to make a difference. So, he saw that need for a solution and he decided to do something about it. Really impressive. So how is he planning to actually tackle this huge problem of wasted research?</p>

<p><strong>Guest:</strong> Well, his idea is to create this tool he calls it “AWARE”, which stands for Avoidably Wasted Research. And he…</p>

<p><strong>Host:</strong> And he…</p>

<p><strong>Guest:</strong> Yeah, and the idea is that AWARE would basically be like an early warning system. You know, it would help researchers catch those red flags for potential waste, really early in the process.</p>

<p><strong>Host:</strong>  I like that. Early detection is key for sure. But okay, paint me a picture here. How would this thing actually work in the real world?</p>

<p><strong>Guest:</strong> So, imagine this. You’re designing a research study, right? And you’re using some kind of outdated measurement tool. Maybe you don’t even realize it’s outdated. But AWARE, AWARE would flag that right away, potentially saving the entire project from going down a rabbit hole later on.</p>

<p><strong>Host:</strong>  That makes a lot of sense. I mean, catching those kinds of things early on could be a game changer.</p>

<p><strong>Guest:</strong> Exactly. And while we don’t know every single detail about how AWARE will work just yet, what we do know from Pavel’s fellowship application is that he’s super serious about this. He’s taking a very collaborative and rigorous approach to developing it.</p>

<p><strong>Host:</strong> Collaboration and rigor, those are definitely two words you want to hear when it comes to something with this kind of potential impact.</p>

<p><strong>Guest:</strong> Absolutely. And to make sure this isn’t just some theoretical exercise, he’s teamed up with the SPOR Evidence Alliance.</p>

<p><strong>Host:</strong> Okay. I’ve heard of them, but remind me what they’re all about.</p>

<p><strong>Guest:</strong> Right. So, the SPOR Evidence Alliance is this really impressive network: Over 400 people, all involved in health research in some way. And we’re not just talking researchers here, we’re talking patients, policy-makers, the whole shebang.</p>

<p><strong>Host:</strong> Oh wow, so they’re really getting those diverse perspectives right from the get-go.</p>

<p><strong>Guest:</strong> Exactly! And that’s huge, right? Because to really create a tool that’s going to be used and actually make a difference, it can’t just be researchers in a bubble. They need those voices from patients, from policy-makers, from the people who are actually going to be impacted by this research.</p>

<p><strong>Host:</strong>  That makes so much sense. So, how is Pavel making sure that AWARE can stand up to real-world scrutiny? How do we know it’s actually going to work?</p>

<p><strong>Guest:</strong> He’s got this really comprehensive, like, three-pronged approach planned. A scoping review, interviews with stakeholders and then actually testing it out on real-world research reports.</p>

<p><strong>Host:</strong>  Okay. I’m going to need you to break that down for me. What does all of that actually involve?</p>

<p><strong>Guest:</strong>  Sure. So, the scoping review, that’s basically like a superpowered literature review. It’s about mapping out absolutely everything that’s already known about a particular topic, which in this case is, you guessed it, research waste.</p>

<p><strong>Host:</strong> Right.</p>

<p><strong>Guest:</strong> Then, he’s going to be interviewing members of this SPOR Evidence Alliance, picking their brains. You know, getting their insights on research waste. How they see AWARE fitting in? All of that.</p>

<p><strong>Host:</strong>  That’s smart. Getting those firsthand perspectives.</p>

<p><strong>Guest:</strong> Totally! And then, here’s a really cool part. He’s actually going to test AWARE out on this collection of real-world research reports that the Alliance has already produced. We’re talking over 280 reports, so it’s not just theory. He’s really putting this thing through its paces.</p>

<p><strong>Host:</strong> Right. Wow, talk about putting it through the ringer. But how can we be sure that AWARE doesn’t end up as just another research paper, you know, sitting on a shelf somewhere, gathering dust. How will he make sure that it actually leads to real changes in how research is done?</p>

<p><strong>Guest:</strong> That’s where this thing called the “Knowledge-to-Action Cycle” comes in. Have you heard of that?</p>

<p><strong>Host:</strong>  It rings a bell, but refresh my memory.</p>

<p><strong>Guest:</strong> Yeah. So, it’s this framework actually developed by CIHR themselves, and it basically emphasizes that it’s not enough to just create new knowledge, right? You have to make sure that knowledge is actually usable and useful in the real world.</p>

<p><strong>Host:</strong>  Yeah.</p>

<p><strong>Guest:</strong> And Pavel has built this framework into AWARE from the very beginning.</p>

<p><strong>Host:</strong>  That’s really interesting. So he’s using CIHR’s own framework to potentially revolutionize how CIHR-funded research is conducted. Very meta. And speaking of making things usable, I love that he’s developing both an online version and a paper-based version of AWARE. And in multiple languages, too. It really shows that he’s committed to making this tool accessible to as many people as possible.</p>

<p><strong>Guest:</strong> I agree. That’s a really important point because what good is an amazing tool if nobody can use it, right? That commitment to accessibility is going to be crucial if we’re serious about tackling this global problem of wasted research.</p>

<p><strong>Host:</strong>  It sounds like Pavel really understands that for something like AWARE to be successful, it needs to be embraced by a diverse international community of researchers. That’s thinking ahead! It’s pretty amazing to think about AWARE being used by researchers all over the world, potentially. But let’s zoom out for a sec. Get the bigger picture here. Where does this project fit in with all the talk about making research better, more accountable, you know?</p>

<p><strong>Guest:</strong> Oh, that’s a great question. You see, Pavel’s work is part of this, like, growing movement. People pushing for more transparency and accountability in research. You ever heard of Retraction Watch?</p>

<p><strong>Host:</strong> Yeah, for sure! They do some really important work, exposing those flawed studies after they’ve already been published.</p>

<p><strong>Guest:</strong> Exactly! And what’s really interesting here is that Pavel’s work with AWARE, it’s like, what if we could prevent that waste in the first place? It’s kind of like preventative medicine, but for the research world.</p>

<p><strong>Host:</strong> Preventative research, I like that. So much better to catch these issues early on, right? Assuming AWARE actually works the way it’s supposed to, what’s the long game here? What’s Pavel’s vision for the future?</p>

<p><strong>Guest:</strong> Well, this fellowship he’s gotten now, it’s really just the first step.</p>

<p><strong>Host:</strong> Yeah.</p>

<p><strong>Guest:</strong> You see, he’s already thinking ahead, trying to secure funding to really scale up AWARE. Take it beyond this initial pilot phases. His ultimate goal, imagine a world where every single research study, every grant proposal, all gets assessed for potential waste using AWARE. That’s the dream.</p>

<p><strong>Host:</strong> That’s a pretty ambitious goal, I got to say. And if it works, I mean, think of the impact! Researchers could use funding way more effectively, breakthroughs could happen faster and ultimately…</p>

<p><strong>Guest:</strong> Exactly! It all comes down to better health for everyone. And that’s what makes Pavel’s work so inspiring, you know. It’s not just about numbers and data, it’s about actually improving, maybe even saving, lives.</p>

<p><strong>Host:</strong>  He seems like he’s really passionate about making research more accessible, more impactful. And it’s not just with AWARE, right?</p>

<p><strong>Guest:</strong>  Oh, absolutely not! This guy’s got a lot going on. Yeah! He also created this online portal, it’s all about making research findings easier for everyday folks to understand. And on top of that, he’s always on social media advocating for evidence-based practice. You know, getting the word out. It’s pretty impressive!</p>

<p><strong>Host:</strong> It really is! It makes you think, what if, because of people like Pavel and tools like AWARE, we could take even a small chunk of those billions of dollars being wasted on bad research and use it to solve some of the world’s biggest health problems? Imagine the progress we could make! It’s exciting to think about, right?</p>

<p><strong>Guest:</strong> Absolutely! It just goes to show how important this all is! And, you know, research, it never stops evolving. It’s an ongoing process, and tools like AWARE, they’re crucial for making sure that research is done right, responsibly. So that, ultimately, everyone benefits. Something to keep in mind.</p>

<p><strong>Host:</strong>  Absolutely. Great point to end on. Well, thanks so much for breaking all of that down for us today. It’s been a fascinating deep dive.</p>

<p><strong>Guest:</strong> My pleasure. Always happy to be here.</p>]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[Oh, nothing unusual—just a robot talking to itself about AWARE.]]></summary></entry><entry><title type="html">Подкаст 85% — Эпизод 1</title><link href="https://researchwaste.info/ru/2024/09/21/85-percent-podcast-e1" rel="alternate" type="text/html" title="Подкаст 85% — Эпизод 1" /><published>2024-09-21T00:00:00+00:00</published><updated>2024-09-21T00:00:00+00:00</updated><id>https://researchwaste.info/ru/2024/09/21/85-percent-podcast-e1</id><content type="html" xml:base="https://researchwaste.info/ru/2024/09/21/85-percent-podcast-e1"><![CDATA[<p>Ничего необычного — просто робот, разговаривающий сам с собой об AWARE.</p>

<p>Прошло более 2 месяцев с момента запуска сайта <a href="https://researchwaste.info">researchwaste.info</a>, и мне посчастливилось получить массу полезных отзывов, за которые я очень благодарен.</p>

<p>Пока я пересматриваю план диссертации, первый эпизод моего <a href="https://podcasters.spotify.com/pod/show/researchwaste">подкаста «85%» (на английском)</a> — это взгляд в будущее. Этот роботизированный подкаст был создан с помощью <a href="https://notebooklm.google.com/">NotebookLM</a> из пакета документов, который я сейчас составляю для подачи заявки на <a href="https://cihr-irsc.gc.ca/e/50513.html">финансирование Канадских институтов исследований в здравоохранении</a>. Пожелайте мне удачи!</p>

<p><strong>Слушать на русском:</strong></p>

<p><i class="fa fa-music" aria-hidden="true"></i> <a href="/assets/media/85_percent_e1_ru.mp3">Скачать MP3-аудиофайл</a></p>

<p>Ниже вы найдете расшифровку этого эпизода (конечно же, сгенерированную ИИ! Опять же спасибо Google):</p>

<hr />
<p><strong>Ведущая:</strong> Мы так сильно верим в исследования в области здравоохранения, в новые методы лечения, в лекарства. Но всё это сводится к исследованиям. А что, если я скажу вам, что большая часть этих исследований может оказаться бесполезной?</p>

<p><strong>Гость:</strong> Да, к сожалению, это правда. Есть исследования, которые показывают, что до 85% исследований в области здравоохранения оказываются бесполезными. Мы говорим о миллиардах долларов, о бесчисленных часах работы, и всё это ради очень незначительных результатов.</p>

<p><strong>Ведущая:</strong> Хорошо, давайте разберёмся. Миллиарды долларов потрачены впустую — это просто безумие. Но что мы имеем в виду, когда говорим о бесполезных исследованиях? Ведь не всегда речь идёт о плохих исследованиях или о подтасовке фактов. Не так ли?</p>

<p><strong>Гость:</strong> Нет, ты права. Мошенничество — это проблема, не пойми меня неправильно. Но большая часть этих бесполезных исследований связана с менее очевидными, но не менее важными проблемами. Например, исследования, которые плохо спланированы или просто повторяют то, что мы уже знаем, или даже исследования, которые ставят вопросы, которые никто не задаёт.</p>

<p><strong>Ведущая:</strong> То есть это как построить высокотехнологичный мост, но забыть проверить, есть ли кому вообще переходить через реку?</p>

<p><strong>Гость:</strong> Точно. И дело в том, что это не просто абстрактная академическая проблема. Это касается всех: тебя, меня, всех, кого мы знаем. Подумай об этом: прорывы в лечении заболеваний, возможно, даже в поиске лекарств, тормозятся из-за бесполезных исследований. И это также означает, что некоторые методы лечения, которые мы используем сейчас, могут быть не такими эффективными, как могли бы быть.</p>

<p><strong>Ведущая:</strong> Когда ты так говоришь, это немного пугает. Задержки в исследованиях и развитии медицины из-за того, что исследования заходят в тупик, заставляют задуматься. Что меня действительно поразило в истории Павла, так это то, что он решил найти решение, увидев своими глазами, к чему приводят напрасные исследования. Вы можете почувствовать его страсть, его желание изменить ситуацию. Он увидел, что нужно найти решение, и решил что-то предпринять. Это действительно впечатляет. Так как же он собирается решить эту огромную проблему напрасных исследований?</p>

<p><strong>Гость:</strong> Ну, его идея заключается в создании инструмента. Он назвал его «осведомлённость», что означает «избежание напрасных исследований».</p>

<p><strong>Ведущая:</strong> И она…</p>

<p><strong>Гость:</strong> Да, идея заключается в том, что «осведомлённость» будет своего рода системой раннего предупреждения. Понимаете? Она поможет исследователям выявлять признаки напрасных исследований на ранних этапах работы.</p>

<p><strong>Ведущая:</strong> Мне нравится, что раннее выявление проблемы — это ключ к успеху. Но давайте представим, как это будет работать в реальном мире. Как это будет выглядеть на практике?</p>

<p><strong>Гость:</strong> Итак, представьте, что вы разрабатываете исследование, верно? И вы используете какой-то устаревший инструмент для измерения. Возможно, вы даже не осознаёте, что он устарел, но «осведомлённость» сразу же это обнаружит. И это поможет вам избежать ошибок в дальнейшем.</p>

<p><strong>Ведущая:</strong> Это имеет смысл. Я имею в виду, что раннее выявление подобных вещей может изменить ситуацию к лучшему.</p>

<p><strong>Гость:</strong> Именно. И хотя мы пока не знаем всех деталей того, как будет работать «осведомлённость», из заявки Павла на стипендию мы знаем, что он очень серьёзно относится к этому. Он использует очень строгий и комплексный подход к разработке этого инструмента.</p>

<p><strong>Ведущая:</strong> Сотрудничество и строгость — это именно те слова, которые хочется услышать, когда речь идёт о чём-то, что может оказать такое влияние.</p>

<p><strong>Гость:</strong> Совершенно верно. И чтобы убедиться, что это не просто теоретическое упражнение, он объединился с организацией «Альянс за Доказательства».</p>

<p><strong>Ведущая:</strong> Хорошо, я слышала о них, но напомни мне, чем они занимаются.</p>

<p><strong>Гость:</strong> Ладно, итак. «Альянс за Достоверные Доказательства» — это действительно впечатляющая организация, в которую входит более 400 человек. Так или иначе связанных с исследованиями в области здравоохранения. И мы говорим не только о самих исследователях, но и о пациентах, политиках. В общем, обо всех, кто вовлечён в этот процесс.</p>

<p><strong>Ведущая:</strong> О, ничего себе! Значит, они действительно привлекают к работе самые разные точки зрения.</p>

<p><strong>Гость:</strong> Именно. И это очень важно, ведь чтобы создать инструмент, который будет использоваться и действительно изменит ситуацию, недостаточно просто привлечь исследователей. Им нужны голоса пациентов, политиков, людей, на которых эти исследования действительно повлияют.</p>

<p><strong>Ведущая:</strong> Это так разумно. Как Павел собирается сделать так, чтобы AWARE выдержал проверку в реальном мире? Откуда мы знаем, что это действительно сработает?</p>

<p><strong>Гость:</strong> У него есть действительно продуманный трёхсторонний подход: обзор, интервью с заинтересованными лицами и тестирование на реальных отчётах о проведённых исследованиях.</p>

<p><strong>Ведущая:</strong> Хорошо, мне нужно, чтобы ты объяснил мне, что это значит.</p>

<p><strong>Гость:</strong> Конечно. Итак, обзор — это, по сути, расширенный обзор литературы. Он заключается в том, чтобы собрать абсолютно всё, что уже известно по определённой теме. В данном случае, как вы уже догадались, об отходах исследований.</p>

<p><strong>Ведущая:</strong> Верно?</p>

<p><strong>Гость:</strong> Затем он будет брать интервью у членов «Альянса за Достоверные Доказательства», чтобы узнать их мнение. Ну, знаешь, как они видят внедрение AWARE в их работу.</p>

<p><strong>Ведущая:</strong> Это разумно, получить информацию из первых рук.</p>

<p><strong>Гость:</strong> Точно. И вот что самое интересное. Он собирается протестировать AWARE на базе уже имеющихся у «Альянса» отчётов о реальных исследованиях. Мы говорим о более чем 280 отчётах. Значит, это не просто теория. Он действительно использует этот инструмент для достижения своих целей.</p>

<p><strong>Ведущая:</strong> Верно. Вау! Это что-то вроде проверки на прочность. Но как мы можем быть уверены, что AWARE не превратится в очередную исследовательскую работу, которая будет пылиться на полке? И как он сможет убедиться, что это действительно приведёт к реальным изменениям в исследовательской деятельности?</p>

<p><strong>Гость:</strong> Вот тут-то и вступает в игру «Цикл Знания — Действие». Вы слышали об этом?</p>

<p><strong>Ведущая:</strong> Что-то припоминаю, но напомни мне.</p>

<p><strong>Гость:</strong> Да, эта концепция, разработанная CIHR самими. И она подчёркивает, что недостаточно просто создавать новые знания, верно? Нужно убедиться, что эти знания действительно применимы и полезны в реальном мире.</p>

<p><strong>Ведущая:</strong> Да.</p>

<p><strong>Гость:</strong> И Павел с самого начала внедрил эту концепцию в AWARE.</p>

<p><strong>Ведущая:</strong> Это действительно интересно! Он использует собственную концепцию CIHR для того, чтобы потенциально изменить подход к финансированию исследований CIHR. Это очень метафорично. И если говорить о том, чтобы сделать что-то полезным, мне нравится, что он разрабатывает онлайн-версию AWARE и бумажную версию на нескольких языках. Это действительно показывает, что он стремится сделать этот инструмент доступным для как можно большего числа людей.</p>

<p><strong>Гость:</strong> Я согласен. Это действительно важный момент, потому что какой толк от потрясающего инструмента, если никто не может им пользоваться? Эта доступность будет иметь решающее значение, если мы серьёзно настроены решить проблему нерационального использования научных исследований.</p>

<p><strong>Ведущая:</strong> Похоже, Павел действительно понимает, что для того, чтобы проект AWARE был успешным, его должно принять международное сообщество исследователей, которые думают наперёд. Это удивительно, что AWARE может использоваться исследователями по всему миру! Но давайте на секунду отвлечёмся и посмотрим на картину в целом. Как этот проект вписывается в контекст исследований, которые становятся более прозрачными и подотчётными, понимаете?</p>

<p><strong>Гость:</strong> О, это отличный вопрос! Видите ли, работа Павла — это часть растущего движения. Люди стремятся к большей прозрачности, подотчётности и развитию исследований. Вы когда-нибудь слышали о Retraction Watch?</p>

<p><strong>Ведущая:</strong> Да, конечно. Они делают очень важную работу, выявляя недостатки в исследованиях, которые уже были опубликованы.</p>

<p><strong>Гость:</strong> Именно. И что действительно интересно, так это то, что работа Павла с AWARE — это как если бы мы могли предотвратить потери на начальном этапе. Это что-то вроде превентивной медицины, но для мира исследований.</p>

<p><strong>Ведущая:</strong> Превентивные исследования! Мне нравится это выражение. Гораздо лучше выявлять проблемы на ранней стадии, верно? Если предположить, что AWARE действительно работает так, как задумано, то каковы дальнейшие планы? Каким видит будущее Павел?</p>

<p><strong>Гость:</strong> Ну, эта стипендия, которую он сейчас получает, — это всего лишь первый шаг.  Вы знаете, он уже думает о том, как привлечь финансирование для дальнейшего развития AWARE, вывести его за рамки этого начального этапа. Это его конечная цель. Представьте мир, в котором каждое исследование, каждое предложение по гранту оцениваются на предмет возможных потерь с помощью AWARE. Это мечта.</p>

<p><strong>Ведущая:</strong> Это довольно амбициозная цель, должна сказать. И если это сработает, то представьте, какой будет результат! Исследователи смогут более эффективно использовать финансирование, а открытия будут происходить быстрее, и, в конечном итоге…</p>

<p><strong>Гость:</strong> Именно! Всё это приведёт к улучшению здоровья для всех. И именно поэтому работа Павла так вдохновляет. Понимаете, дело не только в цифрах и данных, дело в том, чтобы действительно улучшить, а может быть, даже спасти жизни.</p>

<p><strong>Ведущая:</strong> Он, кажется, очень увлечён тем, чтобы сделать исследования более доступными и эффективными. И это касается не только AWARE, верно?</p>

<p><strong>Гость:</strong> О, это совершенно точно. У этого парня много чего происходит в жизни.</p>

<p><strong>Ведущая:</strong> Да.</p>

<p><strong>Гость:</strong> Он также создал онлайн-портал, который помогает людям, не имеющим специального образования, разобраться в результатах исследований. И вдобавок ко всему, он постоянно выступает в социальных сетях за применение научно-обоснованных методов, чтобы донести информацию до людей. Это впечатляет!</p>

<p><strong>Ведущая:</strong> Это действительно впечатляет! И заставляет задуматься, что, если бы благодаря таким людям, как Павел, и таким инструментам, как AWARE, мы могли бы сэкономить хотя бы часть тех миллиардов долларов, которые тратятся на некачественные исследования, и использовать их для решения самых серьёзных мировых проблем со здоровьем? Только представьте, какого прогресса мы могли бы достичь! Вы ведь об этом думаете, верно?</p>

<p><strong>Гость:</strong> Абсолютно верно. Это лишний раз доказывает, насколько всё это важно. И, вы знаете, что исследования никогда не прекращаются. Это непрерывный процесс, и такие инструменты, как AWARE, необходимы для того, чтобы исследования проводились правильно и ответственно и, в конечном итоге, приносили пользу всем. Это нужно иметь в виду.</p>

<p><strong>Ведущая:</strong> Абсолютно. Это отличная мысль, которой можно закончить. Что же, спасибо, что рассказали нам всё это сегодня. Это было очень познавательно.</p>

<p><strong>Гость:</strong> Рад был помочь.</p>

<hr />]]></content><author><name>Pavel Zhelnov</name></author><summary type="html"><![CDATA[Ничего необычного — просто робот, разговаривающий сам с собой об AWARE.]]></summary></entry></feed>